Clinical Trial Update: Lorazepam for the Treatment of Status Epilepticus in Children [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 trial evaluating lorazepam for the treatment of status epilepticus in children. The study is sponsored by NICHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Status Epilepticus | Phase 1 | Status: COMPLETED